FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2095160815> ?p ?o ?g. }

• W2095160815 endingPage "141" @default.
• W2095160815 startingPage "137" @default.
• W2095160815 abstract "Abstract: Mycophenolate mofetil (MMF) is a new immunosuppressive agent that blocks de novo purine synthesis in T and B lymphocytes via a potent selective inhibition of inosine monophosphate dehydrogenase. MMF has been shown to significantly reduce the incidence of acute rejection in both adult and pediatric renal transplantation. The impact of MMF on routine antibody induction therapy in pediatric renal transplantation has not been defined. Remarkably, a recent North American Pediatric Transplant Cooperative Study concluded that T-cell antibody induction therapy was deleterious for patients who received MMF. Our study examines the use of MMF in an evolving immunosuppressive strategy to avoid antibody induction in both living (LD) and cadaver (CAD) donor pediatric renal transplantation. We retrospectively analyzed the records of 43 pediatric renal transplants that received MMF-based triple therapy without antibody induction therapy between November 1996 and April 2000. We compared CAD (n = 17) with LD (n = 26). The two groups were similar demographically except that CAD had significantly younger donors than LD, 26.1 ± 13.7 vs. 36.2 ± 9.2 yr (p = 0.006). All the patients received MMF at 600 mg/m2/b.i.d. (maximum dose of 2 g/d) and prednisone with cyclosporine (86%) or tacrolimus (14%). Mean follow-up was >36 months for each group. Acute rejection rate at 6 months was 11.8% (CAD) vs. 15.4% (LD) (p = 0.999) and at 1 yr was 23.5% (CAD) vs. 26.9% (LD) (p = 0.999). Mean estimated glomerular filtration rate (ml/min/1.73 m2) at 6 months was 73.3 ± 15.3 (CAD) vs. 87.6 ± 24.2 (LD) (p = 0.068). Patient survival at 1, 2, and 3 yr was 100, 100, and 100% for CAD vs. 100, 96, and 96% for LD, respectively. Graft survival at 1, 2, and 3 yr was 100, 100, and 94% for CAD vs. 96, 88, and 71% for LD, respectively. Graft loss in CAD was because of chronic rejection (n = 2) while in LD it was because of non-compliance (n = 6), post-transplant lymphoproliferative disorder (n = 1), and sepsis (n = 1). In conclusion, MMF without antibody induction in both CAD and LD pediatric renal transplantation provides statistically similar and effective prophylaxis against acute rejection at 6 months and 1 yr post-transplant. The short-term patient and graft survival rates are excellent, however, non-compliance remains a serious challenge to long-term graft survival. Additional controlled studies are needed to define the role of MMF without antibody induction therapy in pediatric renal transplantation." @default.
• W2095160815 created "2016-06-24" @default.
• W2095160815 creator A5009748781 @default.
• W2095160815 creator A5015972523 @default.
• W2095160815 creator A5024384898 @default.
• W2095160815 creator A5048858164 @default.
• W2095160815 creator A5049754563 @default.
• W2095160815 creator A5054145136 @default.
• W2095160815 creator A5086005215 @default.
• W2095160815 date "2003-03-21" @default.
• W2095160815 modified "2023-09-26" @default.
• W2095160815 title "Mycophenolate mofetil without antibody induction in cadaver vs. living donor pediatric renal transplantation" @default.
• W2095160815 cites W2032634709 @default.
• W2095160815 cites W2053405208 @default.
• W2095160815 cites W2074567821 @default.
• W2095160815 cites W2088171565 @default.
• W2095160815 cites W2105942506 @default.
• W2095160815 cites W2154269068 @default.
• W2095160815 cites W2286127041 @default.
• W2095160815 cites W2316408469 @default.
• W2095160815 cites W4247193560 @default.
• W2095160815 cites W50336179 @default.
• W2095160815 doi "https://doi.org/10.1034/j.1399-3046.2003.00035.x" @default.
• W2095160815 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12654055" @default.
• W2095160815 hasPublicationYear "2003" @default.
• W2095160815 type Work @default.
• W2095160815 sameAs 2095160815 @default.
• W2095160815 citedByCount "5" @default.
• W2095160815 countsByYear W20951608152012 @default.
• W2095160815 countsByYear W20951608152017 @default.
• W2095160815 crossrefType "journal-article" @default.
• W2095160815 hasAuthorship W2095160815A5009748781 @default.
• W2095160815 hasAuthorship W2095160815A5015972523 @default.
• W2095160815 hasAuthorship W2095160815A5024384898 @default.
• W2095160815 hasAuthorship W2095160815A5048858164 @default.
• W2095160815 hasAuthorship W2095160815A5049754563 @default.
• W2095160815 hasAuthorship W2095160815A5054145136 @default.
• W2095160815 hasAuthorship W2095160815A5086005215 @default.
• W2095160815 hasConcept C126322002 @default.
• W2095160815 hasConcept C126894567 @default.
• W2095160815 hasConcept C128057223 @default.
• W2095160815 hasConcept C141071460 @default.
• W2095160815 hasConcept C159641895 @default.
• W2095160815 hasConcept C2777630719 @default.
• W2095160815 hasConcept C2778033501 @default.
• W2095160815 hasConcept C2778720950 @default.
• W2095160815 hasConcept C2780303639 @default.
• W2095160815 hasConcept C2909675724 @default.
• W2095160815 hasConcept C2909935303 @default.
• W2095160815 hasConcept C2911091166 @default.
• W2095160815 hasConcept C38596361 @default.
• W2095160815 hasConcept C71924100 @default.
• W2095160815 hasConcept C90924648 @default.
• W2095160815 hasConceptScore W2095160815C126322002 @default.
• W2095160815 hasConceptScore W2095160815C126894567 @default.
• W2095160815 hasConceptScore W2095160815C128057223 @default.
• W2095160815 hasConceptScore W2095160815C141071460 @default.
• W2095160815 hasConceptScore W2095160815C159641895 @default.
• W2095160815 hasConceptScore W2095160815C2777630719 @default.
• W2095160815 hasConceptScore W2095160815C2778033501 @default.
• W2095160815 hasConceptScore W2095160815C2778720950 @default.
• W2095160815 hasConceptScore W2095160815C2780303639 @default.
• W2095160815 hasConceptScore W2095160815C2909675724 @default.
• W2095160815 hasConceptScore W2095160815C2909935303 @default.
• W2095160815 hasConceptScore W2095160815C2911091166 @default.
• W2095160815 hasConceptScore W2095160815C38596361 @default.
• W2095160815 hasConceptScore W2095160815C71924100 @default.
• W2095160815 hasConceptScore W2095160815C90924648 @default.
• W2095160815 hasIssue "2" @default.
• W2095160815 hasLocation W20951608151 @default.
• W2095160815 hasLocation W20951608152 @default.
• W2095160815 hasOpenAccess W2095160815 @default.
• W2095160815 hasPrimaryLocation W20951608151 @default.
• W2095160815 hasRelatedWork W1639716242 @default.
• W2095160815 hasRelatedWork W1966639716 @default.
• W2095160815 hasRelatedWork W1970601178 @default.
• W2095160815 hasRelatedWork W2024905006 @default.
• W2095160815 hasRelatedWork W2091927377 @default.
• W2095160815 hasRelatedWork W2146394451 @default.
• W2095160815 hasRelatedWork W2807485254 @default.
• W2095160815 hasRelatedWork W3082549382 @default.
• W2095160815 hasRelatedWork W3183209022 @default.
• W2095160815 hasRelatedWork W4254835997 @default.
• W2095160815 hasVolume "7" @default.
• W2095160815 isParatext "false" @default.
• W2095160815 isRetracted "false" @default.
• W2095160815 magId "2095160815" @default.
• W2095160815 workType "article" @default.